These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
337 related articles for article (PubMed ID: 31175849)
1. Donor-specific circulating cell free DNA as a noninvasive biomarker of graft injury in heart transplantation. Macher HC; García-Fernández N; Adsuar-Gómez A; Porras-López M; González-Calle A; Noval-Padillo J; Guerrero JM; Molinero P; Borrego-Domínguez JM; Herruzo-Avilés Á; Rubio A Clin Chim Acta; 2019 Aug; 495():590-597. PubMed ID: 31175849 [TBL] [Abstract][Full Text] [Related]
2. HLA-DRB1 mismatch-based identification of donor-derived cell free DNA (dd-cfDNA) as a marker of rejection in heart transplant recipients: A single-institution pilot study. Sorbini M; Togliatto GM; Simonato E; Boffini M; Cappuccio M; Gambella A; Arruga F; Mora N; Marro M; Caorsi C; Mansouri M; Magistroni P; Delsedime L; Papotti MG; Amoroso A; Rinaldi M; Vaisitti T; Deaglio S J Heart Lung Transplant; 2021 Aug; 40(8):794-804. PubMed ID: 34134912 [TBL] [Abstract][Full Text] [Related]
3. Noninvasive detection of graft injury after heart transplant using donor-derived cell-free DNA: A prospective multicenter study. Khush KK; Patel J; Pinney S; Kao A; Alharethi R; DePasquale E; Ewald G; Berman P; Kanwar M; Hiller D; Yee JP; Woodward RN; Hall S; Kobashigawa J Am J Transplant; 2019 Oct; 19(10):2889-2899. PubMed ID: 30835940 [TBL] [Abstract][Full Text] [Related]
5. Comparing Plasma Donor-derived Cell-free DNA to Gene Expression in Endomyocardial Biopsies in the Trifecta-Heart Study. Halloran PF; Reeve J; Mackova M; Madill-Thomsen KS; Demko Z; Olymbios M; Campbell P; Melenovsky V; Gong T; Hall S; Stehlik J Transplantation; 2024 Sep; 108(9):1931-1942. PubMed ID: 38538559 [TBL] [Abstract][Full Text] [Related]
6. Cell-free DNA donor fraction analysis in pediatric and adult heart transplant patients by multiplexed allele-specific quantitative PCR: Validation of a rapid and highly sensitive clinical test for stratification of rejection probability. North PE; Ziegler E; Mahnke DK; Stamm KD; Thomm A; Daft P; Goetsch M; Liang HL; Baker MA; Vepraskas A; Rosenau C; Dasgupta M; Simpson P; Mitchell ME; Tomita-Mitchell A PLoS One; 2020; 15(1):e0227385. PubMed ID: 31929557 [TBL] [Abstract][Full Text] [Related]
7. Sex-specific patterns of donor-derived cell-free DNA in heart transplant rejection: An analysis from the Genomic Research Alliance for Transplantation (GRAfT). DeFilippis EM; Sweigart B; Khush KK; Shah P; Agbor-Enoh S; Valantine HA; Vest AR J Heart Lung Transplant; 2024 Jul; 43(7):1135-1141. PubMed ID: 38460620 [TBL] [Abstract][Full Text] [Related]
8. Progress in Noninvasive Surveillance for Acute Rejection in Pediatric Heart Transplant Recipients: A Real-World Analysis of Donor-Derived Cell-Free DNA-Based Surveillance Protocol. Akabas L; Bravo SA; Zhang Y; Simonelli A; Zuckerman WA; Richmond ME; Lytrivi ID Clin Transplant; 2024 Oct; 38(10):e15481. PubMed ID: 39412485 [TBL] [Abstract][Full Text] [Related]
9. The Trifecta Study: Comparing Plasma Levels of Donor-derived Cell-Free DNA with the Molecular Phenotype of Kidney Transplant Biopsies. Halloran PF; Reeve J; Madill-Thomsen KS; Demko Z; Prewett A; Billings P; J Am Soc Nephrol; 2022 Feb; 33(2):387-400. PubMed ID: 35058354 [TBL] [Abstract][Full Text] [Related]
11. Circulating cell-free DNA as a biomarker of tissue injury: Assessment in a cardiac xenotransplantation model. Agbor-Enoh S; Chan JL; Singh A; Tunc I; Gorham S; Zhu J; Pirooznia M; Corcoran PC; Thomas ML; Lewis BGT; Jang MK; Ayares DL; Horvath KA; Mohiuddin MM; Valantine H J Heart Lung Transplant; 2018 Aug; 37(8):967-975. PubMed ID: 29933912 [TBL] [Abstract][Full Text] [Related]
12. Clinical Examples of the Additive Value of Absolute Quantification of Cell-Free DNA After Heart Transplantation. Böhmer J; Wåhlander H; Karason K; Sunnegårdh J; Wasslavik C; Jonsson M; Asp J; Ricksten A; Dellgren G Clin Transplant; 2024 Oct; 38(10):e15477. PubMed ID: 39422356 [TBL] [Abstract][Full Text] [Related]
13. Preliminary clinical experience applying donor-derived cell-free DNA to discern rejection in pediatric liver transplant recipients. Zhao D; Zhou T; Luo Y; Wu C; Xu D; Zhong C; Cong W; Liu Q; Zhang J; Xia Q Sci Rep; 2021 Jan; 11(1):1138. PubMed ID: 33441886 [TBL] [Abstract][Full Text] [Related]
14. Racial Differences in Donor-Derived Cell-Free DNA and Mitochondrial DNA After Heart Transplantation, on Behalf of the GRAfT Investigators. Shah P; Agbor-Enoh S; Lee S; Andargie TE; Sinha SS; Kong H; Henry L; Park W; McNair E; Tchoukina I; Shah KB; Najjar SS; Hsu S; Rodrigo ME; Jang MK; Marboe C; Berry GJ; Valantine HA; Circ Heart Fail; 2024 Apr; 17(4):e011160. PubMed ID: 38375637 [TBL] [Abstract][Full Text] [Related]
15. Donor fraction cell-free DNA and rejection in adult and pediatric heart transplantation. Richmond ME; Zangwill SD; Kindel SJ; Deshpande SR; Schroder JN; Bichell DP; Knecht KR; Mahle WT; Wigger MA; Gaglianello NA; Pahl E; Simpson PM; Dasgupta M; North PE; Hidestrand M; Tomita-Mitchell A; Mitchell ME J Heart Lung Transplant; 2020 May; 39(5):454-463. PubMed ID: 31983667 [TBL] [Abstract][Full Text] [Related]
16. Analytical Validation of a Single-nucleotide Polymorphism-based Donor-derived Cell-free DNA Assay for Detecting Rejection in Kidney Transplant Patients. Altuğ Y; Liang N; Ram R; Ravi H; Ahmed E; Brevnov M; Swenerton RK; Zimmermann B; Malhotra M; Demko ZP; Billings PR; Ryan A Transplantation; 2019 Dec; 103(12):2657-2665. PubMed ID: 30801536 [TBL] [Abstract][Full Text] [Related]
17. Absolute quantification of donor-derived cell-free DNA as a marker of rejection and graft injury in kidney transplantation: Results from a prospective observational study. Oellerich M; Shipkova M; Asendorf T; Walson PD; Schauerte V; Mettenmeyer N; Kabakchiev M; Hasche G; Gröne HJ; Friede T; Wieland E; Schwenger V; Schütz E; Beck J Am J Transplant; 2019 Nov; 19(11):3087-3099. PubMed ID: 31062511 [TBL] [Abstract][Full Text] [Related]
18. Donor-derived cell-free DNA (dd-cfDNA) for detection of allograft rejection in pediatric kidney transplants. Puliyanda DP; Swinford R; Pizzo H; Garrison J; De Golovine AM; Jordan SC Pediatr Transplant; 2021 Mar; 25(2):e13850. PubMed ID: 33217125 [TBL] [Abstract][Full Text] [Related]
19. Graft-derived cell-free DNA, a noninvasive early rejection and graft damage marker in liver transplantation: A prospective, observational, multicenter cohort study. Schütz E; Fischer A; Beck J; Harden M; Koch M; Wuensch T; Stockmann M; Nashan B; Kollmar O; Matthaei J; Kanzow P; Walson PD; Brockmöller J; Oellerich M PLoS Med; 2017 Apr; 14(4):e1002286. PubMed ID: 28441386 [TBL] [Abstract][Full Text] [Related]
20. The use of plasma donor-derived, cell-free DNA to monitor acute rejection after kidney transplantation. Gielis EM; Ledeganck KJ; Dendooven A; Meysman P; Beirnaert C; Laukens K; De Schrijver J; Van Laecke S; Van Biesen W; Emonds MP; De Winter BY; Bosmans JL; Del Favero J; Abramowicz D Nephrol Dial Transplant; 2020 Apr; 35(4):714-721. PubMed ID: 31106364 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]